1394 related articles for article (PubMed ID: 33693551)
41. Aspergillus Test Profiles and Mortality in Critically Ill COVID-19 Patients.
Ergün M; Brüggemann RJM; Alanio A; Dellière S; van Arkel A; Bentvelsen RG; Rijpstra T; van der Sar-van der Brugge S; Lagrou K; Janssen NAF; Buil JB; van Dijk K; Melchers WJG; Reijers MHE; Schouten JA; Wauters J; Cordey A; Soni S; White PL; van de Veerdonk FL; Verweij PE
J Clin Microbiol; 2021 Nov; 59(12):e0122921. PubMed ID: 34495710
[TBL] [Abstract][Full Text] [Related]
42. Risk factors for COVID-19 associated pulmonary aspergillosis and outcomes in patients with acute respiratory failure in a respiratory sub-intensive care unit.
Iacovelli A; Oliva A; Mirabelli FM; Giannone S; Laguardia M; Morviducci M; Nicolardi ML; Repaci E; Sanzari MT; Leanza C; Raponi G; Mastroianni C; Palange P
BMC Infect Dis; 2024 Apr; 24(1):392. PubMed ID: 38605300
[TBL] [Abstract][Full Text] [Related]
43. Clinical characteristics, bacterial coinfections and outcomes in COVID-19-associated pulmonary aspergillosis in a third-level Mexican hospital during the COVID-19 pre-vaccination era.
Hernández-Silva G; Corzo-León DE; Becerril-Vargas E; Peralta-Prado AB; Odalis RG; Morales-Villarreal F; Ríos-Ayala MA; Alonso TG; Agustín FD; Ramón AF; Hugo AV
Mycoses; 2024 Jan; 67(1):e13693. PubMed ID: 38214372
[TBL] [Abstract][Full Text] [Related]
44. Incidence and mortality of COVID-19-associated pulmonary aspergillosis: A systematic review and meta-analysis.
Mitaka H; Kuno T; Takagi H; Patrawalla P
Mycoses; 2021 Sep; 64(9):993-1001. PubMed ID: 33896063
[TBL] [Abstract][Full Text] [Related]
45. Incidence, risk factors and pre-emptive screening for COVID-19 associated pulmonary aspergillosis in an era of immunomodulant therapy.
van Grootveld R; van der Beek MT; Janssen NAF; Ergün M; van Dijk K; Bethlehem C; Stads S; van Paassen J; Heunks LMA; Bouman CSC; Reijers MHE; Brüggeman RJ; van de Veerdonk FL; van Bree SHW; van den Berg CHSB; Kuindersma M; Wauters J; Beishuizen A; Verweij PE; Schouten JA;
J Crit Care; 2023 Aug; 76():154272. PubMed ID: 36801598
[TBL] [Abstract][Full Text] [Related]
46. Nebulized Amphotericin B in Mechanically Ventilated COVID-19 Patients to Prevent Invasive Pulmonary Aspergillosis: A Retrospective Cohort Study.
Melchers M; van Zanten ARH; Heusinkveld M; Leeuwis JW; Schellaars R; Lammers HJW; Kreemer FJ; Haas PJ; Verweij PE; van Bree SHW
Crit Care Explor; 2022 May; 4(5):e0696. PubMed ID: 35558738
[TBL] [Abstract][Full Text] [Related]
47. Lateral flow assay (LFA) in the diagnosis of COVID-19-associated pulmonary aspergillosis (CAPA): a single-center experience.
Serin I; Baltali S; Cinli TA; Goze H; Demir B; Yokus O
BMC Infect Dis; 2022 Nov; 22(1):822. PubMed ID: 36348480
[TBL] [Abstract][Full Text] [Related]
48. Aspergillosis in Critically Ill Patients with and Without COVID-19 in a Tertiary Hospital in Southern Brazil.
Trápaga MR; Poester VR; Basso RP; Blan BDS; Munhoz LS; Pasqualotto AC; Werner TDF; Figurelli ML; Stevens DA; von Groll A; Xavier MO
Mycopathologia; 2024 Jun; 189(3):48. PubMed ID: 38847987
[TBL] [Abstract][Full Text] [Related]
49. COVID-Associated Pulmonary Aspergillosis and Its Related Outcomes: A Single-Center Prospective Observational Study.
Iqbal A; Ramzan M; Akhtar A; Ahtesham A; Aslam S; Khalid J
Cureus; 2021 Aug; 13(8):e16982. PubMed ID: 34527462
[TBL] [Abstract][Full Text] [Related]
50. Incidence and inhospital outcomes of coronavirus disease 2019-associated pulmonary aspergillosis in the United States.
Sharma A; Sharma A; Soubani AO
Ann Thorac Med; 2024; 19(1):87-95. PubMed ID: 38444990
[TBL] [Abstract][Full Text] [Related]
51. Mortality in critically ill patients with coronavirus disease 2019-associated pulmonary aspergillosis: A systematic review and meta-analysis.
Singh S; Verma N; Kanaujia R; Chakrabarti A; Rudramurthy SM
Mycoses; 2021 Sep; 64(9):1015-1027. PubMed ID: 34057252
[TBL] [Abstract][Full Text] [Related]
52. Risk factors and clinical impact of COVID-19-associated pulmonary aspergillosis: Multicenter retrospective cohort study.
Lee R; Cho SY; Lee DG; Ahn H; Choi H; Choi SM; Choi JK; Choi JH; Kim SY; Kim YJ; Lee HJ
Korean J Intern Med; 2022 Jul; 37(4):851-863. PubMed ID: 35611611
[TBL] [Abstract][Full Text] [Related]
53. Invasive pulmonary aspergillosis in patients with acute respiratory syndrome by COVID-19.
Sánchez Martín C; Madrid Martínez E; González Pellicer R; Armero Ibáñez R; Martínez González E; Llau Pitarch JV
Rev Esp Anestesiol Reanim (Engl Ed); 2022 Jan; 69(1):48-53. PubMed ID: 35033481
[TBL] [Abstract][Full Text] [Related]
54. Prospective and systematic screening for invasive aspergillosis in the ICU during the COVID-19 pandemic, a proof of principle for future pandemics.
van Grootveld R; van Paassen J; Claas ECJ; Heerdink L; Kuijper EJ; de Boer MGJ; van der Beek MT;
Med Mycol; 2024 May; 62(5):. PubMed ID: 38544330
[TBL] [Abstract][Full Text] [Related]
55. COVID-19 associated pulmonary aspergillosis in critically-ill patients: a prospective multicenter study in the era of Delta and Omicron variants.
Bay P; Audureau E; Préau S; Favory R; Guigon A; Heming N; Gault E; Pham T; Chaghouri A; Turpin M; Morand-Joubert L; Jochmans S; Pitsch A; Meireles S; Contou D; Henry A; Joseph A; Chaix ML; Uhel F; Roux D; Descamps D; Emery M; Garcia-Sanchez C; Levy D; Burrel S; Mayaux J; Kimmoun A; Hartard C; Pène F; Rozenberg F; Gaudry S; Brichler S; Guillon A; Handala L; Tamion F; Moisan A; Daix T; Hantz S; Delamaire F; Thibault V; Souweine B; Henquell C; Picard L; Botterel F; Rodriguez C; Dessap AM; Pawlotsky JM; Fourati S; de Prost N;
Ann Intensive Care; 2024 Apr; 14(1):65. PubMed ID: 38658426
[TBL] [Abstract][Full Text] [Related]
56. Defining COVID-19-associated pulmonary aspergillosis: systematic review and meta-analysis.
Kariyawasam RM; Dingle TC; Kula BE; Vandermeer B; Sligl WI; Schwartz IS
Clin Microbiol Infect; 2022 Jul; 28(7):920-927. PubMed ID: 35150878
[TBL] [Abstract][Full Text] [Related]
57. Pulmonary Aspergillosis in Critically Ill COVID-19 Patients Admitted to the Intensive Care Unit: A Retrospective Cohort Study.
Bergmann F; Jorda A; Blaschke A; Gabler C; Bohdan S; Nussbaumer-Pröll A; Radtke C; Zeitlinger M
J Fungi (Basel); 2023 Mar; 9(3):. PubMed ID: 36983483
[TBL] [Abstract][Full Text] [Related]
58. Lower respiratory tract single-cell RNA sequencing and neutrophil extracellular trap profiling of COVID-19-associated pulmonary aspergillosis: a single centre, retrospective, observational study.
Feys S; Vanmassenhove S; Kraisin S; Yu K; Jacobs C; Boeckx B; Cambier S; Cunha C; Debaveye Y; Gonçalves SM; Hermans G; Humblet-Baron S; Jansen S; Lagrou K; Meersseman P; Neyts J; Peetermans M; Rocha-Pereira J; Schepers R; Spalart V; Starick MR; Thevissen K; Van Brussel T; Van Buyten T; Van Mol P; Vandenbriele C; Vanderbeke L; Wauters E; Wilmer A; Van Weyenbergh J; Van De Veerdonk FL; Carvalho A; Proost P; Martinod K; Lambrechts D; Wauters J
Lancet Microbe; 2024 Mar; 5(3):e247-e260. PubMed ID: 38280387
[TBL] [Abstract][Full Text] [Related]
59. Proven COVID-19-associated pulmonary aspergillosis in patients with severe respiratory failure.
Fortarezza F; Boscolo A; Pezzuto F; Lunardi F; Jesús Acosta M; Giraudo C; Del Vecchio C; Sella N; Tiberio I; Godi I; Cattelan A; Vedovelli L; Gregori D; Vettor R; Viale P; Navalesi P; Calabrese F
Mycoses; 2021 Oct; 64(10):1223-1229. PubMed ID: 34157166
[TBL] [Abstract][Full Text] [Related]
60. COVID-19-associated pulmonary aspergillosis (CAPA): how big a problem is it?
Fekkar A; Neofytos D; Nguyen MH; Clancy CJ; Kontoyiannis DP; Lamoth F
Clin Microbiol Infect; 2021 Sep; 27(9):1376-1378. PubMed ID: 34192575
[No Abstract] [Full Text] [Related]
[Previous] [Next] [New Search]
